Effects of Vitamins and Common Drugs on Reduction of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Rat Microsomes

Archives of Physiology and Biochemistry

Volumn 109, Issue 2, 2001, Pages 175-179

  Leung, Y K ^a   Ho, J W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemo prevention; Clonidine; Crocetin; Modulation; NNAL; NNK; Tolbutamide; Tumorigenesis; Vitamins

Indexed keywords

NICOTIANA TABACUM;

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDIABETIC AGENT; ANTIOXIDANT; ATROPINE; CARCINOGEN; CIMETIDINE; CLONIDINE; CYTOCHROME P450; ENZYME INHIBITOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NITROSAMINE; THIOCTIC ACID; TOLBUTAMIDE; VITAMIN;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; LIVER MICROSOME; MALE; METABOLISM; OXIDATION REDUCTION REACTION; RAT; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTIOXIDANTS; ATROPINE; CARCINOGENS; CIMETIDINE; CLONIDINE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HYPOGLYCEMIC AGENTS; MALE; MICROSOMES, LIVER; MUSCARINIC ANTAGONISTS; NITROSAMINES; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID; TOLBUTAMIDE; VITAMINS;

EID: 0035323308     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/apab.109.2.175.4265     Document Type: Article

References (27)

1. Alworth WL, Young-Sciame R, Hecht SS (1993): Inhibition of NNK mouse lung tumorigenesis by arylalkynes. mechanism-based inactivators of cytochrome P450. Carcinogenesis 14: 1711-1713.
2. Atalla A, Maser E (1999): Carbonyl reduction of the tobacco-specific nitrosamino 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung. Toxicol 139(1): 155-166.
3. Back DJ, Tjia J, Monig H, Ohnhaus EE, Park BK (1988): Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. Eur J Clin Pharmacol 34: 157-163.
4. Bradford MM (1976): A rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Cnubben NHP, Vervoort J, Veeger C, Rietjens IMCM (1992): Study on the regioselectivity and mechanism of the aromatic hydroxylation of monofluoroanilines. Chem-Biol Interact 85: 151-172.
6. Desai D, Chang L, Amin S (1996): Synthesis and bioassay of 4-ipomeanol analogs as potential chemopreventive agents against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced tumorigenicity in A/J mice. Cancer Lett 108: 263-270.
7. Guo Z, Smith T, Thomas PE, Yang CS (1992): Metabolism of NNK by inducible and constitutive cytochrome P450 enzymes in rats. Arch Biochem Biophys 298(1): 279-286.
8. Hanrahan JP, Gordon MA (1984): Vitamins and Coenzymes. J Am Med Assoc 251: 1057-1098.
9. Hargaden MB, Rahim YI, Vesell ES (1999): Metabolism and disposition of NNK in rhesus monkeys. Drug Metab Dispos 27(4): 471-478.
10. Hecht SS (1994): Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab Rev 26: 373-90.
11. Hecht SS (1996): Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl-1-butanone , a tobacco-specific lung carcinogen. Crit Rev in Toxcol 26(2): 163-181.
12. Hecht SS, Jordan KG, Choi CI, Trushin N (1990): Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 11(6): 1017-1020.
13. Hoffmann D, Rivenson A, Hecht SS (1996): The biological significance of tobacco-specific N-nitrosamines: smoking and adencarcinoma of the lung. Crit Rev Toxicol 26(2): 199-211.
14. Inaba T, Jurima M, Mahon WA, Kalow W (1988): In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Drug Metab Dispos 13(4): 443-448.
15. Ioannides C, Rodrigues AD, Ayrton AD, Barnett CR, Chown J, Parke DV (1989): Induction of the rat hepatic microsomal mixed-function oxidases by cimetidine. Toxicol Lett 49: 61-68.
16. Maser E (1998): 11 beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific for carbonyl reduction of the tobacco-specific nitrosamino 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes. Cancer Res 58(14): 2996-3003, 1998.
17. Maser E, Richter E, Friebertshauser J (1996): Identification of 11 β-hydroxysteroid dehydrogenase s carbonyl reductase of the tobacco-specific nitrosamines (NNK). Eur J Biochem 238: 484-489.
18. Morse MA, Eklind KI, Hecht SS, Jordan KG, Choi CI, Desai DH, Amin SG, Chung F-L (1991): Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced lung tumorigenesis by arylalkyl isothiocyanates in A J mice. Cancer Res 51: 1846-1850.
19. Morse MA, Toburen AL (1996): Inhibition of metabolic activation of NNK by limonene. Cancer Lett 104: 211-217.
20. Morse MA, Wang CX, Stoner GD, Mandai S, Conran PB, Amin SG, Hecht SS, Chung F-L (1989): Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res 49: 549-553.
21. Smith GBJ, Castonguay A, Donnelly PJ, Reid KR, Petsikas D, Massey TE (1999): Biotransformation of the tobacco-specific carcinogen NNK in freshly isolated human lung cells. Carcinogenesis 20(9): 1809-1818, 1999.
22. Smith TJ, Guo Z, Gonzalez FJ, Guengerich FP, Stoner GD, Yang CS (1992): Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res 52: 1757-1763.
23. Soldan M, Nagel G, Losekam M, Ernst M, Maser E (1999): Interindividual variability in the expression and NNK carbonyl reductase activity of 11 beta-hydroxysteroid dehydrogenase in human lung. Cancer Lett 145(1): 49-56.
24. Stoner GD, Morse MA (1997): Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett 114: 113-119.
25. Szkudelski T, Kandulska K (1999): The effect of myo-inositol on ethanol-induced metabolic changes and insulin concentration in the rat. Arch Physiol Biochem 107: 334-337.
26. Wattenberg LW, Sparnins VL, Barany G (1989): Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res 49: 2689-2692.
27. Wright AWE, Winzor DJ, Reilly PEB (1991): Cimetidine: an inhibitor and an inducer of rat liver microsomal cytochrome P-450. Xenobiotica 21: 193-203.